These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2952905)

  • 1. Quinolinic acid: an endogenous inhibitor specific for type B monoamine oxidase in human brain synaptosomes.
    Naoi M; Ishiki R; Nomura Y; Hasegawa S; Nagatsu T
    Neurosci Lett; 1987 Feb; 74(2):232-6. PubMed ID: 2952905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds.
    Naoi M; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1105-10. PubMed ID: 3346669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
    Naoi M; Nagatsu T
    Life Sci; 1987 Mar; 40(11):1075-82. PubMed ID: 3821373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
    Takamidoh H; Naoi M; Nagatsu T
    Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives.
    Minami M; Maruyama W; Dostert P; Nagatsu T; Naoi M
    J Neural Transm Gen Sect; 1993; 92(2-3):125-35. PubMed ID: 8369106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of type A monoamine oxidase by coptisine in mouse brain.
    Ro JS; Lee SS; Lee KS; Lee MK
    Life Sci; 2001 Dec; 70(6):639-45. PubMed ID: 11833714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H; Arai Y; Toyoshima Y
    Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase by N-methylisoquinolinium ion.
    Naoi M; Hirata Y; Nagatsu T
    J Neurochem; 1987 Mar; 48(3):709-12. PubMed ID: 3806102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholine content and distribution in rat cortical synaptosomes after in vivo exposure to quinolinic acid.
    Metcalf RH; Riddell DL; Boegman RJ
    Neurosci Lett; 1990 Jan; 108(1-2):219-24. PubMed ID: 2137564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl L-alanine and its analogues.
    Naoi M; Nagatsu T
    Life Sci; 1987 Jan; 40(4):321-8. PubMed ID: 3100896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase.
    Naoi M; Matsuura S; Parvez H; Takahashi T; Hirata Y; Minami M; Nagatsu T
    J Neurochem; 1989 Feb; 52(2):653-5. PubMed ID: 2911035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
    Youdim MB; Gross A; Finberg JP
    Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of type A monoamine oxidase by 2(N)-methyl-6,7-dihydroxyisoquinolinium ions.
    Naoi M; Maruyama W; Sasuga S; Deng Y; Dostert P; Ohta S; Takahashi T
    Neurochem Int; 1994 Nov; 25(5):475-81. PubMed ID: 7849576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.
    O'Brien EM; Dostert P; Tipton KF
    Biochem Pharmacol; 1995 Jul; 50(3):317-24. PubMed ID: 7646533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurotoxic actions of quinolinic acid in the central nervous system.
    el-Defrawy SR; Boegman RJ; Jhamandas K; Beninger RJ
    Can J Physiol Pharmacol; 1986 Mar; 64(3):369-75. PubMed ID: 2939936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B.
    Janssens de Varebeke P; Pauwels G; Buyse C; David-Remacle M; De Mey J; Roba J; Youdim MB
    J Neurochem; 1989 Oct; 53(4):1109-16. PubMed ID: 2769256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.